Psyence Biomedical Ltd. Made Big Gain
Thu, Apr 16, 2026 at 07:19 PM
Psyence Biomedical Ltd. (PBM:NASDAQ) soared at $5.87, representing a gain of 106%. On Thu, Apr 16, 2026, PBM:NASDAQ hit a New 2-Week High of $5.87. The stock appeared on our News Catalysts scanner on Tue, Apr 14, 2026 at 02:03 PM in the 'AGREEMENT' category. From Thu, Apr 02, 2026, the stock recorded 66.67% Up Days and 80.00% Green Days
The stock spiked on Thu, Apr 16, 2026 at $9.97 with a volume of 42M+.
About Psyence Biomedical Ltd. (PBM:NASDAQ)
Psyence cultivates natural psilocybin mushrooms (Psilocybe Cubensis) at our federally licensed ISO22000 facility in Southern Africa.
Top 10 Gainers:
- Myseum Inc. (MYSE:NASDAQ), 129.17%
- Onfolio Holdings, Inc. (ONFO:NASDAQ), 124.89%
- Psyence Biomedical Ltd. (PBM:NASDAQ), 105.96%
- Meiwu Technology Company Limited (WNW:NASDAQ), 75.95%
- WeShop Holdings Limited (WSHP:NASDAQ), 73.54%
- Julong Holding Limited (JLHL:NASDAQ), 64.75%
- Mega Fortune Company Limited (MGRT:NASDAQ), 53.96%
- Daré Bioscience, Inc. (DARE:NASDAQ), 51.96%
- Greenland Energy Company (GLND:NASDAQ), 44.99%
- Real Messenger Corporation (RMSG:NASDAQ), 42.46%